Canada's biggest cannabis company is laser-focused on the United States.
The big biotech's pivot from multiple sclerosis to Alzheimer's disease was dealt a decisive blow today.
These strategies can help biotech investors identify winners and losers.
Results from the Apple Heart Study suggest wearables like watches could someday reshape healthcare.
This cannabis company's business is booming, but it's not all good news for investors.
There are no frown lines from investors as the company is about to launch a competitor to Botox.
The high-flying marijuana company's sales soared last quarter, but its losses are mounting.
Here's why these high-income stocks can be owned in retirement portfolios.
Filing for Social Security benefits as soon as you can may be the right move if these situations apply to you.
The average American is pulling in $952 per week, but pay could be heading higher in 2019.
This mega-merger could be on the rocks following objections by high-profile investors.
Sales are skyrocketing at this small-cap marijuana stock, but its expenses are, too.
Here's how this marijuana stock is executing, as well as its plans for the future.
This marijuana stock just landed a consumer-goods Goliath as a strategic adviser.
New Jersey could clear the way for adult use of marijuana later this month.
The pot company could be on the cusp of a surge in sales next year following a key acquisition.
Spousal benefits are a valuable source of retirement income for millions, but not everyone can collect them.
Before investing in pot stocks, you'll want to know these three things.
The stock market has lost some momentum lately and that has marijuana stock investors jittery. Here are some steps to take if the sell-off worsens.
Roche and Biogen are spending big bucks on gene therapy biotech stocks.